|
A Phase I Dose Escalation Study Of TGR-1202, a Novel PI3K-δ Inhibitor, For Patients With Relapsed Or Refractory Hematologic Malignancies |
|
|
|
Title: |
A Phase I Dose Escalation Study Of TGR-1202, a Novel PI3K-δ Inhibitor, For Patients With Relapsed Or Refractory Hematologic Malignancies |
Author: |
Savona, Michael Gutierrez, Martin Lanasa, Mark Deng, Changchun Kuhn, John Sade, Lauren Miskin, Hari Sportelli, Peter Vakkalanka, Swaroop Patel, Manish |
Appeared in: |
Blood |
Paging: |
Volume 122 () nr. 21 pages 4373 |
Year: |
2013 |
Contents: |
|
Publisher: |
American Society of Hematology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|